All 107 SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Holdings
There are 107 SBIO holdings. Top 10 companies weight: 31.00%.
Total Market Cap: $166B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (107 stocks) | +3.26% | 11.23 | 5.82 | 0.26 | +62.76% | +2.07% | 1.17 | ||||||||||
51 | IMTX | Immatics Nv Ordinary Shares | 0.67% | $9.23 | $1.28B | Biotechnology | Healthcare | -15.05% | N/A | N/A | N/A | N/A | N/A | 75 | +104.66% | $19 | -5.40% | 1.29 |
52 | MNKD | Mannkind Corp | 0.64% | $3.98 | $1.26B | Biotechnology | Healthcare | -21.18% | N/A | 42.37 | 4.39 | N/A | N/A | 71 | +90.70% | $7.59 | -2.94% | 0.71 |
53 | MGTX | Meiragtx Holdings Plc | 0.64% | $12.21 | $1.02B | Biotechnology | Healthcare | -1.60% | N/A | 1.62 | N/A | N/A | N/A | 81 | +132.43% | $28 | -3.84% | 1.29 |
54 | WVE | Wave Life Sciences Ltd | 0.60% | $5.73 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +282.90% | $22 | -3.51% | 1.46 |
55 | XNCR | Xencor Inc | 0.59% | $18.81 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +50.61% | $28 | -10.32% | 1.42 |
56 | SPTX | Seaport Therapeutics Inc | 0.55% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
57 | SLDB | Solid Biosciences Inc | 0.55% | $8.45 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +107.10% | $18 | -28.67% | 1.77 |
58 | OLMA | N/A | 0.54% | $11.35 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +258.59% | $41 | -15.44% | 0.72 |
59 | KURA | Kura Oncology Inc | 0.54% | $10.68 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +191.85% | $31 | -10.92% | 1.06 |
60 | VOR | Vor Biopharma Inc Ordinary Shares | 0.53% | $17.45 | $980M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +117.08% | $38 | -43.35% | 1.23 |
61 | GERN | Geron Corp | 0.50% | $1.44 | $951M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +136.11% | $3.40 | +1.60% | 1.16 |
62 | LBRX | Lb Pharmaceuticals Inc | 0.48% | $30.90 | $922M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +45.63% | $45 | 0.00% | 0.58 |
63 | DSGN | Design Therapeutics Inc | 0.48% | $11.87 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +76.92% | $21 | -8.04% | 1.13 |
64 | ANRO | Alto Neuroscience Inc | 0.48% | $25.97 | $973M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +35.27% | $35 | 0.00% | 1.26 |
65 | TBPH | Theravance Biopharma Inc | 0.44% | $16.81 | $872M | Biotechnology | Healthcare | N/A | 12.26 | 7.91 | N/A | N/A | N/A | 55 | +5.12% | $18 | +3.92% | 0.53 |
66 | CLYM | Climb Bio Inc | 0.40% | $12.22 | $663M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +71.28% | $21 | 0.00% | 1.36 |
67 | ACRS | Aclaris Therapeutics Inc | 0.40% | $5.57 | $782M | Biotechnology | Healthcare | -15.62% | N/A | N/A | N/A | N/A | N/A | 75 | +79.53% | $10 | -18.78% | 0.86 |
68 | RIGL | Rigel Pharmaceuticals Inc | 0.40% | $39.67 | $758M | Biotechnology | Healthcare | N/A | 6.87 | 9.01 | N/A | N/A | N/A | 65 | +36.63% | $54 | -1.37% | 1.10 |
69 | OCS | Oculis Holding Ag | 0.39% | $11.73 | $773M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +220.03% | $38 | 0.00% | 0.66 |
70 | ALLO | Allogene Therapeutics Inc | 0.36% | $1.77 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -39.94% | N/A |
71 | CADL | Candel Therapeutics Inc | 0.36% | $9.57 | $706M | Biotechnology | Healthcare | N/A | N/A | 43.48 | N/A | N/A | N/A | 71 | +114.21% | $21 | 0.00% | 1.80 |
72 | SGP | Spyglass Pharma Inc | 0.34% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
73 | FDMT | 4d Molecular Therapeutics Inc Ordinary Shares | 0.34% | $11.09 | $611M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +154.46% | $28 | -14.78% | 1.22 |
74 | NGNE | Neurogene Inc | 0.34% | $37.34 | $616M | Biotechnology | Healthcare | +11.24% | N/A | N/A | N/A | N/A | N/A | 75 | +118.83% | $82 | -26.10% | 1.88 |
75 | RLMD | Relmada Therapeutics Inc | 0.34% | $5 | $651M | Biotechnology | Healthcare | -0.59% | N/A | N/A | N/A | N/A | N/A | 80 | +153.40% | $13 | -29.81% | 0.89 |
76 | TECX | Tectonic Therapeutic Inc | 0.33% | $32.07 | $612M | Biotechnology | Healthcare | -34.69% | N/A | N/A | N/A | N/A | N/A | 77 | +144.59% | $78 | -19.75% | 1.61 |
77 | AGMB | Agomab Therapeutics Nv Adr | 0.32% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
78 | FLGT | Fulgent Genetics Inc | 0.30% | $19.61 | $606M | Diagnostics & Research | Healthcare | N/A | N/A | 7.70 | N/A | N/A | N/A | 62 | -5.66% | $19 | -25.27% | 0.66 |
79 | EIKN | Eikon Therapeutics Inc | 0.30% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
80 | ALT | Altimmune Inc | 0.30% | $2.81 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +449.82% | $15 | -21.79% | 1.53 |
81 | ZURA | Zura Bio Ltd Ordinary Shares Class A | 0.26% | $5.26 | $511M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +197.91% | $16 | 0.00% | 1.49 |
82 | CTNM | Contineum Therapeutics Inc Class A Common Stock | 0.25% | $13.53 | $546M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +65.04% | $22 | 0.00% | 0.75 |
83 | RZLT | Rezolute Inc | 0.25% | $4.45 | $456M | Biotechnology | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 70 | +72.36% | $7.67 | -16.18% | 0.95 |
84 | TENX | Tenax Therapeutics Inc | 0.24% | $15.68 | $372M | Biotechnology | Healthcare | N/A | N/A | 0.30 | N/A | N/A | N/A | 78 | +121.62% | $35 | -65.02% | N/A |
85 | EVMN | Evommune Inc | 0.24% | $11.53 | $448M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +170.08% | $31 | 0.00% | 0.75 |
86 | CCCC | C4 Therapeutics Inc Ordinary Shares | 0.24% | $3.58 | $395M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +272.35% | $13 | -38.34% | 1.75 |
87 | DCTH | Delcath Systems Inc | 0.23% | $12.59 | $454M | Medical Devices | Healthcare | N/A | 880.89 | 25.77 | 1.60 | N/A | N/A | 80 | +71.17% | $22 | +5.05% | N/A |
88 | CMPX | Compass Therapeutics Inc Ordinary Shares | 0.21% | $2.02 | $385M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +320.79% | $8.50 | -16.55% | 1.55 |
89 | UPB | Upstream Bio Inc | 0.21% | $6.98 | $396M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +447.99% | $38 | 0.00% | 1.09 |
90 | ENTA | Enanta Pharmaceuticals Inc | 0.21% | $13.16 | $384M | Biotechnology | Healthcare | +8.56% | N/A | 44.05 | N/A | N/A | N/A | 75 | +60.87% | $21 | -20.55% | 0.94 |
91 | AKBA | Akebia Therapeutics Inc | 0.19% | $1.28 | $370M | Drug Manufacturers - Specialty & Generic | Healthcare | -35.14% | N/A | 28.74 | N/A | N/A | N/A | 80 | +228.13% | $4.20 | -13.87% | 1.25 |
92 | XFOR | X4 Pharmaceuticals Inc | 0.19% | $3.68 | $368M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +215.22% | $12 | -53.85% | 1.50 |
93 | IMRX | Immuneering Corp Class A | 0.17% | $4.29 | $334M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +316.32% | $18 | 0.00% | 0.90 |
94 | SABS | Sab Biotherapeutics Inc | 0.15% | $3.51 | $274M | Biotechnology | Healthcare | N/A | 14.14 | N/A | N/A | N/A | N/A | 75 | +218.52% | $11 | -48.77% | 0.83 |
95 | MGNX | Macrogenics Inc | 0.15% | $4.32 | $275M | Biotechnology | Healthcare | -14.38% | N/A | 60.98 | N/A | N/A | N/A | 64 | +56.25% | $6.75 | -29.89% | 1.46 |
96 | IKT | Inhibikase Therapeutics Inc Ordinary Shares | 0.13% | $2.23 | $272M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +169.06% | $6 | -32.13% | 1.34 |
97 | AVXL | Anavex Life Sciences Corp | 0.13% | $2.42 | $232M | Biotechnology | Healthcare | +0.72% | N/A | 3.85 | N/A | N/A | N/A | 75 | +726.45% | $20 | -36.07% | 1.35 |
98 | FULC | Fulcrum Therapeutics Inc | 0.12% | $3.62 | $237M | Biotechnology | Healthcare | -12.14% | N/A | N/A | N/A | N/A | N/A | 31 | +61.05% | $5.83 | -16.80% | 1.19 |
99 | TARA | Protara Therapeutics Inc Ordinary Shares | 0.12% | $4.07 | $227M | Biotechnology | Healthcare | -19.06% | N/A | N/A | N/A | N/A | N/A | 81 | +552.83% | $27 | -14.17% | 1.08 |
100 | NBP | Novabridge Biosciences Adr | 0.11% | $1.79 | $149M | Biotechnology | Healthcare | N/A | N/A | 2.68 | N/A | N/A | N/A | 75 | +346.93% | $8 | -52.99% | 0.90 |
SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Sector Allocation
HEALTHCARE
89.80%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%